SHIELD THERAPEUTICS PLC (STX) — Q1 Trading Update

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the SHIELD THERAPEUTICS PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the q and a tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. And now I'd like to hand you over to Anders Lundstrom, CEO. Good afternoon, sir. Thank you so much, and welcome everybody to SHIELD THERAPEUTICS quarter one twenty twenty five training update. I'm Anders Lundstrom, the CEO, and together with me today is Santor Schoenberg, who is our CFO. Yeah. I have two slides. So this is our disclaimer, and I leave it up for a few seconds if you are reading it. Let's move on. So let me start with looking back at 2024. So 2024 reflected a significant step up in revenue along with making substantial progress in expanding our global footprint together with our partners. So during the final quarter of twenty twenty four, we took a decisive step to strengthen our balance sheet by securing a $10,000,000 equity funding from our largest shareholder, AUP. And that is really a game changing moment for the company. So now we can look ahead in a very different manner from what we were able to do previously because we spent a lot of time trying to raise money just to make the day to day operations outlook be secured. Now we can start planning more strategically what the next steps for the company will be. Then reflecting on our 2024 performance, we'...